Cargando…

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

Progress in precision medicine is limited by insufficient knowledge of transcriptomic or proteomic features in involved tissues that define pathobiological differences between patients. Here, myectomy tissue from patients with obstructive hypertrophic cardiomyopathy and heart failure is analyzed usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maron, Bradley A., Wang, Rui-Sheng, Shevtsov, Sergei, Drakos, Stavros G., Arons, Elena, Wever-Pinzon, Omar, Huggins, Gordon S., Samokhin, Andriy O., Oldham, William M., Aguib, Yasmine, Yacoub, Magdi H., Rowin, Ethan J., Maron, Barry J., Maron, Martin S., Loscalzo, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870822/ https://www.ncbi.nlm.nih.gov/pubmed/33558530 http://dx.doi.org/10.1038/s41467-021-21146-y

Ejemplares similares

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2022)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Noncontrast T1 values do not correlate to clinically relevant variables in patients with hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Winter Is Coming: The Slippery Slope of Defining Disease and the Implications for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2022)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy
por: Larson, Amy, et al.
Publicado: (2022)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS‐CoV‐2 infection
por: Alba, George A., et al.
Publicado: (2022)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2022)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States
por: Butzner, Michael, et al.
Publicado: (2022)

Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation
por: Larson, Amy, et al.
Publicado: (2021)

The lamp of medicine of Ancient Egypt is still burning
por: Butrous, Ghazwan, et al.
Publicado: (2020)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Molecular mechanisms of cardiovascular benefits of exercise: Running for cover from heart disease
por: Hassan, Mohamed, et al.
Publicado: (2016)

Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials
por: Wertheim, Bradley M., et al.
Publicado: (2019)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Advanced fluorescence microscopy techniques for the life sciences
por: Danial, John S. H., et al.
Publicado: (2016)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Opposing forces and a river into a lake: Relevance to coronary hemodynamics in Kawasaki disease
por: Yacoub, Magdi, et al.
Publicado: (2017)

Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
por: Hauser, Thomas H, et al.
Publicado: (2009)

An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy
por: Ibrahim, Ayman M., et al.
Publicado: (2020)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Characterization of patients with massive hypertrophic cardiomyopathy using contrast-enhanced magnetic resonance imaging: does contrast provide additional information?
por: Chan, Raymond H, et al.
Publicado: (2012)

Global Analysis of the Human Pathophenotypic Similarity Gene Network Merges Disease Module Components
por: Reyes-Palomares, Armando, et al.
Publicado: (2013)

Characterization of tissue heterogeneity by contrast-enhanced cardiovascular magnetic resonance imaging is a powerful predictor of ventricular tachyarrhythmias on ambulatory holter ECG in hypertrophic cardiomyopathy
por: Harrigan, Caitlin J, et al.
Publicado: (2009)

Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy
por: Williams, Lynne K., et al.
Publicado: (2015)

Characterisation of spatiotemporal aortic flow and aortic wall biomechanics in coarctation
por: Aguib, Heba, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5kosgmk0bii1vuvph1223h41r7